Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons.

@article{SzymczakiewiczMultanowska2012SafetyAA,
  title={Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons.},
  author={Agnieszka Szymczakiewicz-Multanowska and M. B. Lattanzi and Allen E. Izu and Daniela Casula and Mariavittoria Sparacio and Csaba Kov{\'a}cs and Nicola Groth},
  journal={Human vaccines & immunotherapeutics},
  year={2012},
  volume={8 5},
  pages={645-52}
}
BACKGROUND Adult and elderly subjects previously immunized with cell culture-derived (CCIV; Optaflu(®)) or egg-derived (TIV; Agrippal(®)) trivalent influenza vaccines were enrolled in two extension studies (E1 and E2) to evaluate safety and immunogenicity after revaccination with CCIV/TIV alone or in combination with concomitant pneumococcal vaccine (PV… CONTINUE READING